Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04873583Phase 3Recruiting
A Phase 3 trial of methylprednisolone injection, prednisolone in focal cerebral arteriopathy (FCA), ischemic stroke, sponsored by Insel Gruppe. Started Nov 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04873583.